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Abstract
Aims The objective of this study is to evaluate the effects of a
paste-like bone substitute material with easy handling proper-
ties and improved mechanical stability on periodontal regen-
eration of intrabony defects in dogs.
Materials and methods Mandibular and maxillary first and
third premolars were extracted, and three-wall intrabony de-
fects were created on second and fourth premolars. After a
healing period of 3 months, acute type defects were filled with
a paste-like formulation of deproteinized bovine bone mineral
(DBBM) (particle size, 0.125–0.25 mm) in a collagenous
carrier matrix (T1), pulverized DBBM (particle size, 0.125–
0.25 mm) without the carrier (T2), or Bio-Oss® granules
(particle size, 0.25–1.00 mm) as control (C). All defects were
covered with a Bio-Gide® membrane. The dogs were
sacrificed after 12 weeks, and the specimens were analyzed
histologically and histometrically.
Results Postoperative healing of all defects was uneventful,
and no histological signs of inflammation were observed in
the augmented and gingival regions. New cementum, new
periodontal ligament, and new bone were observed in all three
groups. The mean vertical bone gain was 3.26 mm (T1),
3.60 mm (T2), and 3.81 mm (C). That of new cementum
was 2.25 mm (T1), 3.88 mm (T2), and 3.53 mm (C). The
differences did not reach statistical significance. The DBBM
particles were both incorporated in new bone and embedded
in immature bone marrow.
Conclusions The results of this preclinical study showed that
the 0.125–0.25-mm DBBM particles in a powder or paste
formulation resulted in periodontal regeneration comparable
to the commercially available DBBM. Osteoconductivity,
in particular, was not affected by DBBM size or paste
formulation.
Clinical relevance The improved handling properties of the
paste-like bone substitute consisting of small DBBM particles
embedded in a collagen-based carrier hold promise for clinical
applications.
Keywords Natural bonemineral . Intrabony defects .
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Introduction
Regenerative periodontal therapy aims at restoring the struc-
ture and function of the periodontium (i.e., periodontal liga-
ment, cementum with inserting connective tissue fibers, and
bone), which have been lost following injury or periodontal
disease [1]. Grafting materials can support bone regeneration
in non-contained type periodontal defects (i.e., supra-alveolar
and two-wall intrabony with a missing buccal bone wall),
particularly when combined with a barrier membrane [2].
Deproteinized bovine bone mineral (DBBM; Bio-Oss®,
Geistlich Pharma, Wolhusen, Switzerland) combined with a
biodegradable collagen barrier membrane (Bio-Gide®,
Geistlich Pharma) is widely used in regenerative periodontal
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therapy [3–9]. However, in some clinical situations, for ex-
ample in non-contained type defects, the DBBM particles are
difficult to apply and to keep in place. This may lead to
mobilization and displacement of the graft particles, which
in turn might negatively affect the stability of the blood clot
and the regenerative process. Several studies have shown the
importance of blood clot stability to prevent apical growth of
the junctional epithelium and enhancement of connective
tissue attachment to the treated root surface (for a review,
see Wikesjo et al. [10]). Thus, there is a demand for DBBM
with improved handling and biological properties.
One possibility to enhance the handling properties and
to immobilize graft particles is to embed them in a carrier
matrix and to apply this premixed composite or paste-like
material into the periodontal defect. While one such
product (Ostim®), a synthetic, nanocrystalline, phase-
pure hydroxyapatite in an aqueous paste, showed a sig-
nificant improvement in clinical parameters [11–13], his-
tological evaluation revealed only limited potential to
promote true periodontal regeneration [14]. Thus, histo-
logical studies are indispensable for the evaluation of the
regenerative potential of new biomaterials. Variables that
may affect the histological and clinical outcomes are
chemical composition of the carrier material as well as
chemical composition and particle size of the bone sub-
stitute material.
The size and geometry of a bone substitute material is
important, since ingrowth of blood vessels and accompanying
tissues should not be obstructed [15]. Thus, particle size may
influence periodontal regeneration including the amount of
new bone. There are different views on the ideal particle size.
Larger particles may leave more space for vascular ingrowth,
whereas small particles may facilitate their use as injectable
paste-like formulations. No differences were observed for
small and large DBBM granules with regard to bone forma-
tion in bone defects [16, 17] and after sinus floor elevation
[18]. When a synthetic biomaterial was used in bone defects,
more bone formation was observed in association with small
particles [19]. There are, however, no data available at present
on the use of a paste-like formulation consisting of very small
DBBM particles and a new carrier material for periodontal
applications.
Therefore, the aim of this preclinical study was to evaluate
histologically and histometrically the effect of a paste-like
formulation of pulverized (0.125–0.25 mm granule size)
DBBM embedded in a carrier in comparison to pulverized
(0.125–025 mm) and medium-sized (0.25–1.00 mm) DBBM
granules without carrier on periodontal tissue healing in the
treatment of experimentally created and self-contained (three-
wall) intrabony defects in dogs.
The null hypothesis is that the paste-like and pulverized
DBBM are as effective as the commercially available DBBM
for the regeneration of three-wall intrabony defects.
Materials and methods
Animal model
Five male Beagle dogs, approximately 15 months old,
weighing 10–15 kg, and bred exclusively for biomedical
research purposes, were used. The animals had an intact
dentition with a healthy periodontium. Animal selection and
management, surgical protocol, and preparation followed rou-
tines were approved by the Institutional Biomatech, Chasse-
sur-Rhône, France. The animals had ad libitum access to water
and a pelleted laboratory diet with the exception of 1 week
immediately post-surgery when they were fed a canned soft
dog food diet. Food was withheld the night preceding surgery.
The surgical procedures were performed under general anes-
thesia according to an already established protocol. The man-
dibular and maxillary first and third premolars were extracted,
and three-wall intrabony defects (5×5×5 mm) were created
on the second and fourth premolars. The defects for the fourth
premolars were always localized mesially of the tooth. The
defects for the second premolars were always localized distal-
ly of the tooth, except at three sites where the defects were
made mesially. The extraction and intrabony defect sites were
allowed to heal for 12 weeks. The remaining dentition re-
ceived oral prophylaxis in conjunction with the extractions.
Experimental approach
Under general anesthesia, vestibular and oral mucoperiosteal
flaps were elevated. The three-wall intrabony defects were
refreshed because original defects showed almost complete
spontaneous healing [20, 21] (Fig. 1a). Following root plan-
ing, a reference notch was made into the root surface at the
base of each defect using a small round bur. Thus, de novo
periodontal ligament tissue can be detected in the histological
sections. The intrabony defects were then randomly assigned
to one of the following treatment groups (14 sites for T1, 14
sites for T2, and 12 sites for C): (T1) a paste-like formulation
of pulverized DBBM with 0.125–0.25 mm particles embed-
ded in a carrier containing collagen types I and III, (T2) a
pulverized formulation of DBBM with 0.125–0.25 mm parti-
cles but without a carrier, and (C) Bio-Oss® granules (0.25–
1.00 mm) (Geistlich Pharma, Wolhusen, Switzerland)
(Fig. 1b). Defects were covered with a resorbable collagen
membrane (Bio-Gide®, Geistlich) with the double-layer tech-
nique (Fig. 1c). The flaps were positioned and sutured in a
coronally displaced position with double-sling sutures
(Seralon® Wiessner) (Fig. 1d). Animals received spiramycin
750,000 IU and metronidazole 125 mg (BUCCOVAL®,
Laboratoire Sogeval), per os, beginning the day before surgery
and continuing for at least 14 days after surgery. Penicillin
150,000 UI procaine and benzathine (Bicillin® C-R, Pfizer)
were injected intramuscularly the day before defect creation.
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The sutures were removed after 14 days. Hygiene procedures
were performed daily including tooth brushing and topical
application of 0.2 % chlorhexidine until suture removal. Oral
hygiene measures were performed twice weekly. Observa-
tions of experimental sites with regards to gingival health,
maintenance of suture line closure, edema, and evidence of
tissue necrosis or infection were made daily until suture re-
moval and at least twice weekly thereafter.
Retrieval of specimens
After 3 months, the animals were sacrificed with an overdose
of pentobarbital sodium. The oral tissues were fixed by per-
fusion with 10 % buffered formalin administered through the
carotid arteries. Jaw segments with surrounding soft tissues
were removed and placed in formalin. The specimens con-
taining the experimental teeth were further subdivided using a
diamond-coated band saw. From the 40 defects, 28 were left
undecalcified and embedded in methyl methacrylate. The
remaining 12 defects were decalcified in 10 % ethylene-
diaminetetraacetic acid and processed for embedding in par-
affin. Mesiodistal serial paraffin sections were cut parallel to
the long axis of the teeth with the microtome set at 8 μm and
stained with hematoxylin and eosin. The reason for using
paraffin histology in addition to undecalcified ground sections
was to have some samples available for a possible future
immunohistochemical evaluation, if required. The undecal-
cified samples embedded in methyl methacrylate were cut in
the same direction into ∼500-μm-thick ground sections. They
were then mounted on Plexiglas slabs and ground to a final
thickness of ∼80 μm. Finally, the sections were superficially
stained with toluidine blue and basic fuchsin.
Data analysis
Qualitative analysis
All histological sections were observed in Zeiss Axioplan
microscope (Carl Zeiss, Göttingen, Germany), and digital
photography of the defects was performed using a
ProgRes® C5 digital camera (Jenoptik Laser, Optik,
Systeme GmbH, Jena, Germany). Particular attention was
paid to the quality and maturity of newly formed bone,
histological signs of inflammation and foreign body reac-
tion, and the presence of multinucleated giant cells on the
bone substitute materials.
Histomorphometric analysis
Both the principal investigator (A.I.) and a very experienced
researcher working for many years in the field of periodontal
histology (D.B.) inspected all histological sections directly in
the microscope at a maximum magnification/resolution. Only
after both examiners agreed on the position of each reference
point, these points were marked and the examiner (A.I.)
started to perform the measurements.
For descriptive and histomorphometric analyses, sections
with the largest defect area were selected, since this was
indicative of the center of the defect. The following histolog-
ical linear measurements were performed by one calibrated
and masked investigator using the software included in the
ProgRes® C5 digital camera as follows:
– Defect height : distance between apical extension of the
root planing (notch) and coronal extension of gingival
margin (in millimeter)
Fig. 1 Views after a surgical
creation of an intrabony
periodontal defect at the distal
aspect of the PM2, b application
of pulverized DBBM filler, c
coverage of the filled defect with
a collagen barrier membrane, and
d flap repositioning and suturing
for primary intention healing
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– Junctional epithelium : distance from coronal to apical
extent of a junctional epithelium along the root surface
(in millimeter)
– Sulcus depth : distance from coronal to apical extent of
sulcus depth along the root surface (in millimeter)
– Cementum regeneration (height): distance between api-
cal extension of the root planing (notch) and the coronal
extension of a continuous layer of new cementum or
cementum-like deposit on the planed root (in millimeter)
– Bone regeneration (height): distance between apical ex-
tension of root planing (notch) and the coronal extension
of regenerated alveolar bone along the planed root (in
millimeter)
Mean and standard deviation were calculated for all
parameters.
Statistical analysis
The number of defects per group was 14 for group T1, 14
for group T2, and 12 for group C. The differences in means
between the three groups were analyzed using nonpara-
metric analysis of variance (Kruskal–Wallis test, PROC
NPAR1WAY, SAS® version 9.2, SAS Institute Inc., Cary,
NC, USA). No sample size/power calculation was
performed. A post hoc power calculation indicated that
Fig. 2 Undecalcified ground
sections from defects filled with
a paste-like DBBM particles
(T1), b pulverized DBBM
particles (T2), and c , d control
0.25–1.0 mm Bio-Oss particles
(C). The arrows demarcate the
notch at the apical end of the
defects. GM demarcates the
gingival margin, aJE demarcates
the most apical extension of the
junctional epithelium, and C and
B demarcate the most coronal
extension of cementum and bone.
Filling of the defect area with new
bone can be seen in all three
groups. Attachment of some
DBBM particles to the root
surface via new cementum was
observed when the dental pulp
was opened at the time of defect
creation
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16 subjects are necessary in each group to reach an alpha of
5 % and a power of 80.
Results
Histological analysis
Postoperative healing of all defects was uneventful. Five out
of 14 defects in T1 were suitable for histomorphometric
analysis. For T2, 11 out of 14 defects and for C 8 out of 12
defects were included in the histomorphometric evaluation.
Reasons for exclusion were as follows: (1) no removal of
cementum and no notch were detected on the root surface in
the histological sections, (2) opening of the dental pulp due to
excessive removal of hard tissues from the root surface, and
(3) technical difficulties during the preparation of histological
samples. The notch and the periodontal defect region were
clearly recognizable (Fig. 2a–d). In a few defects, two notches
were observed (Fig. 2b), likely due to the creation of a second
defect. An opening of the dental pulp was observed in four
defects. The DBBM particles were integrated in new bone in
the defect region adjacent to the root surface (Fig. 2a–d). In
five defects, some DBBM particles were connected to the root
Fig. 3 Representative
photomicrographs demonstrating
the formation of new cementum
(NC) on root dentin (D), new
periodontal ligament (NPL), and
new bone (NB) in a group T1
(paste-like DBBM), b group T2
(pulverized DBBM), and c group
C (control DBBM). d New
cementum formation between the
root and deproteinized bovine
bone mineral (DBBM) particles,
when the dental pulp (P) was
opened during defect creation
Clin Oral Invest (2014) 18:1319–1328 1323
surface via new cementum (Fig. 2d). Number and distribution
of the DBBM particles in the augmented region varied greatly
between defects, but did not reveal any obvious differences
between groups. In all defects, no adverse inflammatory reac-
tions were observed in both the augmented region and the
gingival seal. Some multinucleated osteoclast-like cells were
seen on some DBBM particles in all three groups.
New cementum, new periodontal ligament, and new bone
were observed in all groups (Fig. 3a–c). The cementum was
cellular, quite uniform in thickness, and inserting collagen
fibers were seen in places. In the coronal portion, the cemen-
tum layer was often thinner than in apical locations. The
newly formed periodontal ligament had a width correspond-
ing to that of the original periodontal ligament and contained
many blood vessels, fibroblasts, and collagen fibers. New
cementum connecting DBBM particles with the root surface
and discontinuity of the periodontal ligament was observed in
five defects (one defect in group T1, two defects in group T2,
and two defects in group C). In four of these five defects, the
dental pulp was opened (Fig. 3d). For all three groups, regions
were found, where the DBBM particles were integrated in
dense mature bone (Fig. 4a–c). In the majority of defects, this
occurred in the more apical region of the defects. Likewise, all
three groups showed regions where DBBM particles were
surrounded and connected to one another by a thin layer of
new bone (Fig. 4d–f). The so formed bone–DBBM composite
was typically localized in more marginal defect regions.
DBBM particles were also found surrounded by soft tissue
and without bone being formed on their surface (Fig. 5a–c).
The soft tissue found at these sites resembled either an imma-
ture bone marrow (Fig. 5b) or a soft connective tissue with a
high number of fibroblast-like cells (Fig. 5a, c). In all defects,
remnants of the collagen membrane were clearly recognizable
(Fig. 5d, e). The residual collagen membrane material
consisted of wave-shaped fragments that were intensely
stained in red. Morphology and staining of these fragments
allowed differentiation between residual collagen membrane
and host collagen.
Histomorphometric analysis
The histometric results are shown in Tables 1, 2, 3, and 4. The
defect height from the apical notch to the gingival margin was
on average 6.43 mm (SD 1.46). The mean scores of all defects
(24 defects) were calculated and presented in Table 1. The
mean length of cementum and bone was 3.42 mm (SD 1.99)
and 3.60 mm (SD 1.39), respectively, and that of the connec-
tive tissue, junctional epithelium, and sulcus depth averaged
0.88 (SD 1.00), 1.45 (SD 0.91), and 0.67 mm (SD 0.47),
respectively.
Fig. 4 Representative
photomicrographs showing
integration of DBBM particles in
a–c dense and d–f loose new
bone (NB) for the groups a , d T1
(paste-like DBBM), b , e T2
(pulverized DBBM), and c , f the
control group C (control DBBM)
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The mean defect height was very similar in all groups
(6.16 mm (SD 1.94) for T1, 6.55 mm (SD 1.4) for T2, and
6.44 mm (SD 1.36) for C) and did not reach statistical signif-
icance (P >0.05). All groups showed an increase in new
cementum measuring on average 2.25 (SD 2.24), 3.88 (SD
2.00), and 3.53 mm (SD 1.78) for T1, T2, and C, respectively.
The differences between groups did not reach statistical sig-
nificance (P >0.05) (Tables 2, 3, and 4). All groups showed an
average increase in new bone of 3.26 (SD 1.03), 3.60 (SD
1.66), and 3.81 mm (SD 1.30), respectively. The differences
among the groups did not reach statistical significance (P >
0.05) (Tables 2, 3, and 4). The connective tissue showed a
mean value of 1.45 (SD 1.71), 0.60 (SD 0.55), and 0.92 mm
(SD 0.90) for T1, T2, and C, respectively. The differences
among the groups did not reach statistical significance (P >
0.05) (Tables 2, 3, and 4). The junctional epitheliummeasured
1.78 (SD 0.81), 1.53 (SD 1.12), and 1.16 mm (SD 0.63) for
T1, T2, and C, respectively. The differences among the groups
did not reach statistical significance (P >0.05) (Tables 2, 3,
and 4). The sulcus depth measured 0.68 (SD 0.35), 0.55 (SD
0.32), and 0.83 mm (SD 0.69) for T1, T2, and C, respectively.
The differences among the groups did not reach statistical
significance (P >0.05) (Tables 2, 3, and 4).
Fig. 5 Representative
photomicrographs illustrating
embedding of DBBM particles in
soft tissue without the formation
of new bone for a group T1
(paste-like DBBM), b group T2
(pulverized DBBM), and c group
C (control DBBM). Remnants of
the collagen barrier membrane
(BM) were found in all defects
adjacent to d new bone (NB) and
e DBBM particles. The residual
collagen membrane material
consisted of wave-shaped
fragments that were intensely
stained in red (arrows). These
characteristic features allowed
differentiating of residual
membrane material from host
collagen
Table 1 Histomorphometric analysis of mean scores of all defects (T1,
T2, and C) for cementum, bone, connective tissue, junctional epithelium,
sulcus depth, and defect height (means (millimeter), standard deviations,
standard error, minimum, maximum, median)
Variable Number Mean Std
dev
Std
error
Minimum Maximum Median
C 24 3.42 1.99 0.41 0.18 7.65 3.64
B 24 3.60 1.39 0.28 0.75 5.72 3.56
CT 24 0.88 1.00 0.20 0.00 4.21 0.60
JE 24 1.45 0.91 0.19 0.46 4.44 1.31
SD 24 0.67 0.47 0.10 0.15 2.33 0.59
DH 24 6.43 1.46 0.30 3.53 9.01 6.35
C cementum, B bone, CT connective tissue, JE junctional epithelium,
SD sulcus depth, DH defect height
Table 2 Histomorphometric analysis of mean scores of T1 (paste-like
DBBM) for cementum, bone, connective tissue, junctional epithelium,
sulcus depth, and defect height (means (mm), standard deviations, stan-
dard error, minimum, maximum, median)
Variable Number Mean Std
dev
Std
error
Minimum Maximum Median
C 5 2.25 2.24 1.00 0.18 5.48 1.31
B 5 3.26 1.03 0.46 1.85 4.76 3.25
CT 5 1.45 1.71 0.76 0.00 4.21 1.21
JE 5 1.78 0.81 0.36 0.80 3.03 1.62
SD 5 0.68 0.35 0.16 0.23 1.16 0.72
DH 5 6.16 1.94 0.87 3.72 9.01 6.24
No statistically significant differences between the paste-like, pulverized,
and control DBBM for all parameters; P>0.05
C cementum, B bone, CT connective tissue, JE junctional epithelium,
SD sulcus depth, DH defect height
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Discussion
This study investigated healing and periodontal regeneration
of three-wall intrabony defects in dogs filled with a paste-like
bone filler consisting of 0.125–0.25-mm DBBM particles
embedded in a collagenous carrier in comparison to 0.125–
0.25 mm large and to commercially available 0.25–1.00 mm
large DBBM particles without the addition of the carrier
material. Unexpectedly, complete bone fill was observed
3 months after the first defect creation. This shows that such
defects in dogs have a high spontaneous healing potential.
Nevertheless, the similar histological and histomorphometrical
outcome for the three biomaterials tested after the second
surgical intervention clearly shows that the two new formula-
tions did not negatively interfere with periodontal healing and
regeneration when compared with the commercially available
and well-documented DBBM. Furthermore, it should be
clearly pointed out that the aim of this study was to evaluate
the tissue responses to the three tested biomaterials. Therefore,
in order to minimize/eliminate confounding factors like bac-
terial challenge through plaque microorganisms as seen in
chronic defects, acute type three-wall defects were used. After
the positive results of the present study, the next experiments
can be performed in a clinically more relevant but also more
challenging situation like a chronic defect and in a larger
sample number allowing proper statistical analysis.
All three groups showed no inflammatory reactions and
resulted in comparable amounts of new cementum, new peri-
odontal ligament, and new bone. Furthermore, integration of
the DBBM particles in new bone was observed for all three
groups. These results are consistent with studies using a
combination of commercially available DBBM (Bio-Oss®)
and a collagen barrier membrane (Bio-Gide®) in two-wall
intrabony [22], one-wall intrabony [23], and fenestration de-
fects [24] in canines.
The barrier membrane
The need for the use of a barrier membrane [23, 24] and the
beneficial effect of the placement of DBBM underneath the
membrane [22] to achieve periodontal regeneration has clearly
been demonstrated. In the present study, the collagen barrier
membrane was placed in a double-layer technique. Our ob-
servation that residual membrane material was found in all
defects after 3 months indicates a long-lasting barrier function,
as was shown for the double-layer technique in other defect
models [25, 26]. Thus, it may be concluded that for all groups
in the present study, comparable conditions in terms of barrier
function existed, which lowered the chance for confounding
factors interfering with the regenerative process.
Granule size
Bone substitute materials are available in different granule
sizes. A DBBM granule size of 0.25–1.00 mm is recommend-
ed for periodontal applications. Using particle sizes smaller
than 0.25–1.00mmmay be beneficial for applications in small
or narrow periodontal bone defects and may allow their pas-
sage through the tip of a syringe when used as an injectable
bone substitute material. To the best of our knowledge, this is
the first study where 0.125–0.25 mm granules with or without
a carrier material were tested in periodontal defects. Granules
with a small particle size may have an influence on their
degradation/resorption rate, on the speed and amount of bone
formation, and on ankylosis.
Ankylosis was not observed in the present study, yet a
connection of some DBBM particles with the root surface
via cementum was seen in five defects. DBBM connection
via hard tissue to the root surface has occasionally been
observed in other studies [27, 28]. Since this phenomenon
Table 3 Histomorphometric analysis of mean scores of T2 (pulverized
DBBM) group for cementum, bone, connective tissue, junctional epithe-
lium, sulcus depth, and defect height (means (millimeter), standard devi-
ations, standard error, minimum, maximum, median)
Variable Number Mean Std
dev
Std
error
Minimum Maximum Median
C 11 3.88 2.00 0.60 1.11 7.65 3.65
B 11 3.60 1.66 0.50 0.75 5.45 4.03
CT 11 0.60 0.55 0.16 0.00 1.55 0.55
JE 11 1.53 1.12 0.34 0.52 4.44 1.26
SD 11 0.55 0.32 0.10 0.15 1.10 0.53
DH 11 6.55 1.44 0.43 3.53 8.60 7.17
No statistically significant differences between the paste-like, pulverized,
and control DBBM for all parameters; P>0.05
C cementum, B bone, CT connective tissue, JE junctional epithelium,
SD sulcus depth, DH defect height
Table 4 Histomorphometric analysis of mean scores of C (control
DBBM) for cementum, bone, connective tissue, junctional epithelium,
sulcus depth, and defect height (mean (millimeter), standard deviations,
standard error, minimum, maximum, median)
Variable Number Mean Std
dev
Std
error
Minimum Maximum Median
C 8 3.53 1.78 0.63 1.22 6.51 3.55
B 8 3.81 1.30 0.46 2.14 5.72 3.55
CT 8 0.92 0.90 0.32 0.00 2.31 0.56
JE 8 1.16 0.63 0.22 0.46 2.35 1.21
SD 8 0.83 0.69 0.24 0.15 2.33 0.65
DH 8 6.44 1.36 0.48 4.84 8.68 6.25
No statistically significant differences between the paste-like, pulverized,
and control DBBM for all parameters; P>0.05
C cementum, B bone, CT connective tissue, JE junctional epithelium,
SD sulcus depth, DH defect height
1326 Clin Oral Invest (2014) 18:1319–1328
was observed in one defect of group T1, two defects of group
T2, and two defects of group C, the particle size is unlikely
responsible for this. In four of these five defects, the pulp was
opened. Thus, it is likely that pulp opening caused an inter-
ruption of periodontal ligament expansion leading to this
phenomenon. Pulp opening likely occurred because defect
creation occurred twice.
Although multinucleated osteoclast-like cells are normally
found on DBBM particles and other calcium phosphate bio-
materials [29], the degradation rate of DBBM is very low
[30–32]. In the present study, osteoclast-like cells were seen
on some DBBM particle in all three groups, and no pro-
nounced signs of resorption such as deep Howship’s lacunae
or extremely small DBBM particles, as demonstrated in an-
other studies [16, 22–24, 28], were observed. Thus, it is
concluded that neither the 0.125–0.25 mm DBBM particles
nor the carrier enhanced the resorptive activity.
Concerning the amount of augmented bone and integration
of DBBM particles in bone, no qualitative differences be-
tween small and large DBBM particles were observed in the
present study. Similar conclusions were made for sinus floor
elevation [18] and the regeneration of calvarial defects [17]. In
contrast, a higher bone density was observed with small
synthetic bone substitute granules (0.3–0.5 mm) compared
with larger (0.85–1.00 mm) granules in another bone defect
model [19]. Thus, our data suggest that the osteoconductive
properties of the small 0.125–0.25 mm DBBM particles are
comparable to those of the larger 0.25–1.00 mm DBBM
particles. However, one drawback of the present study was
that we had to refrain from a histometrical evaluation of area
fractions of new bone and DBBM. Due to the fact that defect
morphology was so heterogeneous, and since the distribution
of the DBBM particles and the density of both DBBM and
new bone were so variable from defect to defect, any possible
material-related differences may have been overruled by this
heterogeneity. Reasons for this heterogeneity may be related
to the fact that defect creation was performed twice due to
spontaneous healing of the first defect and defect creation on
different tooth types with different root morphologies and
both in the lower and upper jaws. There was a big variation
of the scores within the groups of all parameters (cementum,
bone, connective tissue, junctional epithelium, sulcus depth,
and defect height).
The carrier/scaffold
A carrier may influence the osteoconductivity of a bone
substitute material, alter the migration behavior of the parti-
cles, and/or elicit unwanted tissue responses like enhanced
inflammation. Our data suggest that the presence of the carrier
did not negatively influence bone formation and did not result
in adverse tissue reactions. A similar conclusion was drawn
from a bone defect study, where a hydrogen carrier consisting
of carboxymethyl cellulose and collagen was used [17].
Clinical relevance and conclusions
From a clinical standpoint, a paste-like bone substitute mate-
rial, which can easily be injected in a periodontal defect, may
enhance handling and mechanical stability. The biomaterials
tested in the present study did not differ in regard to both their
periodontal regenerative capacity and osteoconductivity. It
may thus be concluded that the 0.125–0.25-mm DBBM par-
ticles combined with the collagen-based carrier may be suit-
able for clinical applications.
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